Nexentis Technologies Inc. (NXTS)

↓ Download CSV

CIK 0001789192 · Nasdaq · Pharmaceutical Preparations

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Dec 31

Key ratios (FY2025)

-25.5%
Return on equity
Metric (FY)202520242023202220212020201920182017
Revenue$210.0K$263.0K$394.0K$438.1K$232.3K$175.8K$426.6K
Cost of Revenue$165.0K$55.0K$158.3K$135.9K$43.4K$144.5K$111.1K
Gross Profit$45.0K$208.0K$235.7K$302.2K$188.9K$31.3K$315.5K
Operating Income-$4.23M-$3.28M-$7.58M-$5.82M-$4.70M-$1.35M-$1.93M-$518.7K
Net Income-$4.00M-$5.19M-$6.52M-$5.74M-$4.82M-$1.59M-$1.97M-$356.9K
EPS (Diluted)$-3.54$-27.74$-5.43$10.85$-2.06
Total Assets$20.41M$5.46M$7.24M$6.49M$7.60M$687.6K$664.7K$859.2K
Total Liabilities$4.67M$892.0K$786.0K$754.9K$1.18M$1.15M$1.07M$647.7K
Shareholders' Equity$15.73M$4.57M$6.46M$5.74M$6.41M-$465.5K-$402.1K$211.5K-$743.5K
Cash & Equivalents$3.83M$1.92M$4.45M$5.70M$6.75M$242.9K$290.8K$439.8K
Operating Cash Flow-$3.81M-$3.42M-$3.23M-$5.10M-$4.11M-$798.7K-$1.24M-$506.5K
Capital Expenditures$14.0K$51.7K$67.7K$23.3K$2.5K
Shares Outstanding2.77M344.7K2.96M688.3K2.81M1.61M1.46M9.23M